Identification of novel candidate target genes, including EPHB3, MASP1 and SST at 3q26.2–q29 in squamous cell carcinoma of the lung

BackgroundThe underlying genetic alterations for squamous cell carcinoma (SCC) and adenocarcinoma (AC) carcinogenesis are largely unknown.MethodsHigh-resolution array- CGH was performed to identify the differences in the patterns of genomic imbalances between SCC and AC of non-small cell lung cancer (NSCLC).ResultsOn a genome-wide profile, SCCs showed higher frequency of gains than ACs (p = 0.067). More specifically, statistically significant differences were observed across the histologic subtypes for gains at 2q14.2, 3q26.2–q29, 12p13.2–p13.33, and 19p13.3, as well as losses at 3p26.2–p26.3, 16p13.11, and 17p11.2 in SCC, and gains at 7q22.1 and losses at 15q22.2–q25.2 occurred in AC (P < 0.05). The most striking difference between SCC and AC was gains at the 3q26.2–q29, occurring in 86% (19/22) of SCCs, but in only 21% (3/14) of ACs. Many significant genes at the 3q26.2–q29 regions previously linked to a specific histology, such as EVI1,MDS1, PIK3CA and TP73L, were observed in SCC (P < 0.05). In addition, we identified the following possible target genes (> 30% of patients) at 3q26.2–q29: LOC389174 (3q26.2),KCNMB3 (3q26.32),EPHB3 (3q27.1), MASP1 and SST (3q27.3), LPP and FGF12 (3q28), and OPA1,KIAA022,LOC220729, LOC440996,LOC440997, and LOC440998 (3q29), all of which were significantly targeted in SCC (P < 0.05). Among these same genes, high-level amplifications were detected for the gene, EPHB3, at 3q27.1, and MASP1 and SST, at 3q27.3 (18, 18, and 14%, respectively). Quantitative real time PCR demonstrated array CGH detected potential candidate genes that were over expressed in SCCs.ConclusionUsing whole-genome array CGH, we have successfully identified significant differences and unique information of chromosomal signatures prevalent between the SCC and AC subtypes of NSCLC. The newly identified candidate target genes may prove to be highly attractive candidate molecular markers for the classification of NSCLC histologic subtypes, and could potentially contribute to the pathogenesis of the squamous cell carcinoma of the lung.

[1]  Calum MacAulay,et al.  Whole genome tiling path array CGH analysis of segmental copy number alterations in cervical cancer cell lines , 2007, International journal of cancer.

[2]  D. M. Parkin,et al.  Corrigendum to “Cancer burden in the year 2000. The global picture” [European Journal of Cancer,37(Suppl. 8) (2001) S4–S66] , 2003 .

[3]  Ajay N. Jain,et al.  Genomic copy number analysis of non-small cell lung cancer using array comparative genomic hybridization: implications of the phosphatidylinositol 3-kinase pathway. , 2002, Cancer research.

[4]  Yeul-Hong Kim,et al.  Comparative genomic hybridization array analysis and real time PCR reveals genomic alterations in squamous cell carcinomas of the lung. , 2007, Lung cancer.

[5]  S. Hirohashi,et al.  Genome‐wide array‐based comparative genomic hybridization analysis of pancreatic adenocarcinoma: Identification of genetic indicators that predict patient outcome , 2007, Cancer science.

[6]  E. Schröck,et al.  Advanced‐stage cervical carcinomas are defined by a recurrent pattern of chromosomal aberrations revealing high genetic instability and a consistent gain of chromosome arm 3q , 1997, Genes, chromosomes & cancer.

[7]  J. Soares,et al.  Chromosome imbalances in thyroid follicular neoplasms: A comparison between follicular adenomas and carcinomas , 2003, Genes, chromosomes & cancer.

[8]  W. Yang,et al.  Genome-wide genetic aberrations of thymoma using cDNA microarray based comparative genomic hybridization , 2007, BMC Genomics.

[9]  P. Massion,et al.  Role of chromosome 3q amplification in lung cancer. , 2008, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[10]  John G. Collard,et al.  Identical chromosome translocations involving the region of the c-myb oncogene in four metastases of a mediastinal teratocarcinoma. , 1985, Cancer genetics and cytogenetics.

[11]  S. Lam,et al.  High resolution analysis of non‐small cell lung cancer cell lines by whole genome tiling path array CGH , 2006, International journal of cancer.

[12]  S. Thiel,et al.  Expression of H-ficolin/Hakata antigen, mannose-binding lectin-associated serine protease (MASP)-1 and MASP-3 by human glioma cell line T98G. , 2003, International immunology.

[13]  D. Xie,et al.  Recurrent chromosomal imbalances in nonsmall cell lung carcinoma , 2004, Cancer.

[14]  Chan Zeng,et al.  Epidermal growth factor receptor in non-small-cell lung carcinomas: correlation between gene copy number and protein expression and impact on prognosis. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  Å. Borg,et al.  Gene products of chromosome 11q and their association with CCND1 gene amplification and tamoxifen resistance in premenopausal breast cancer , 2008, Breast Cancer Research.

[16]  P. Berger,et al.  Christianity and Democracy: The Global Picture , 2004 .

[17]  N. Normanno,et al.  Epidermal growth factor-related peptides and their receptors in human malignancies. , 1995, Critical reviews in oncology/hematology.

[18]  B. Gunawan,et al.  Assessment of molecular events in squamous and non-squamous cell lung carcinoma. , 2006, Lung cancer.

[19]  F. Bray,et al.  Cancer burden in the year 2000. The global picture. , 2001, European journal of cancer.

[20]  E. de Álava,et al.  Pseudomesotheliomatous carcinoma of the lung with a distinct morphology, immunohistochemistry, and comparative genomic hybridization profile. , 2007, Annals of diagnostic pathology.

[21]  T. Mok,et al.  Distinct patterns of genetic alterations in adenocarcinoma and squamous cell carcinoma of the lung. , 2004, European journal of cancer.

[22]  J. Kang,et al.  Genetic Alterations in Primary Gastric Carcinomas Correlated with Clinicopathological Variables by Array Comparative Genomic Hybridization , 2006, Journal of Korean medical science.

[23]  W. Ahn,et al.  Gene expression profiles in squamous cell cervical carcinoma using array-based comparative genomic hybridization analysis , 2006, International Journal of Gynecologic Cancer.

[24]  W. Franklin,et al.  Chromosomal duplication accompanies allelic loss in non-small cell lung carcinoma. , 1998, Cancer research.

[25]  R. Berger,et al.  Y chromosome loss in leukemias , 1979 .

[26]  F. Jiang,et al.  Genomic profiles in stage I primary non small cell lung cancer using comparative genomic hybridization analysis of cDNA microarrays. , 2004, Neoplasia.

[27]  Y. Tagawa,et al.  Comparative genomic hybridization analysis detected frequent overrepresentation of chromosome 3q in squamous cell carcinoma of the lung. , 2002, Lung cancer.

[28]  S. Koo,et al.  High Frequency of Genetic Alterations in Non-small Cell Lung Cancer Detected by Multi-target Fluorescence In Situ Hybridization , 2007, Journal of Korean medical science.

[29]  J. Inazawa,et al.  TERC identified as a probable target within the 3q26 amplicon that is detected frequently in non-small cell lung cancers. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[30]  D. Pinkel,et al.  Genomic Alterations in Primary Gastric Adenocarcinomas Correlate with Clinicopathological Characteristics and Survival , 2004, Cellular oncology : the official journal of the International Society for Cellular Oncology.

[31]  Jane Fridlyand,et al.  Bioinformatics Original Paper a Comparison Study: Applying Segmentation to Array Cgh Data for Downstream Analyses , 2022 .

[32]  J W Gray,et al.  Cytogenetic analysis using quantitative, high-sensitivity, fluorescence hybridization. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[33]  J. Cigudosa,et al.  Expression signatures in lung cancer reveal a profile for EGFR‐mutant tumours and identify selective PIK3CA overexpression by gene amplification , 2008, The Journal of pathology.

[34]  Wen-Lin Kuo,et al.  Amplification of MDS1/EVI1 and EVI1, located in the 3q26.2 amplicon, is associated with favorable patient prognosis in ovarian cancer. , 2007, Cancer research.

[35]  D. Gisselsson,et al.  Statistical dissection of cytogenetic patterns in lung cancer reveals multiple modes of karyotypic evolution independent of histological classification. , 2004, Cancer genetics and cytogenetics.

[36]  C. Pan,et al.  Copy number changes of target genes in chromosome 3q25.3-qter of esophageal squamous cell carcinoma: TP63 is amplified in early carcinogenesis but down-regulated as disease progressed. , 2005, World journal of gastroenterology.

[37]  M. Moran,et al.  Tandem immunoprecipitation of phosphotyrosine-mass spectrometry (TIPY-MS) indicates C19ORF19 becomes tyrosine-phosphorylated and associated with activated epidermal growth factor receptor. , 2008, Journal of proteome research.

[38]  Jeong-Sun Seo,et al.  Genome-wide combination profiling of copy number and methylation offers an approach for deciphering misregulation and development in cancer cells. , 2008, Gene.

[39]  S. Koo,et al.  Gain of the EGFR gene located on 7p12 is a frequent and early event in squamous cell carcinoma of the lung. , 2008, Cancer genetics and cytogenetics.

[40]  Susanne Kneitz,et al.  Ependymoma gene expression profiles associated with histological subtype, proliferation, and patient survival , 2007, Acta Neuropathologica.

[41]  L. Ellis,et al.  Coexpression of ephrin‐Bs and their receptors in colon carcinoma , 2002, Cancer.

[42]  Wonshik Han,et al.  Genomic copy number alterations as predictive markers of systemic recurrence in breast cancer , 2008, International journal of cancer.

[43]  E. Schröck,et al.  Gain of chromosome 3q defines the transition from severe dysplasia to invasive carcinoma of the uterine cervix. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[44]  S. Hirohashi,et al.  Allelotype Analysis of Common Epithelial Ovarian Cancers with Special Reference to Comparison between Clear Cell Adenocarcinoma with Other Histological Types , 2002, Japanese journal of cancer research : Gann.

[45]  Jin Man Kim,et al.  Gain at chromosomal region 5p15.33, containing TERT, is the most frequent genetic event in early stages of non-small cell lung cancer. , 2008, Cancer genetics and cytogenetics.

[46]  Comparative genomic hybridization analysis suggests a gain of chromosome 7p associated with lymph node metastasis in non-small cell lung cancer. , 2001, Oncology reports.